1. World Health Organization. (1998). Fact Sheet No. 135: Population Ageing – A Public Health Challenge. Geneva: World Health Organization. 

2. United Nations, Department of Economic and Social Affairs, Population Division. (2019). World Population Prospects.

3. India Census. (2011). Population Census. New Delhi, India: Ministry of Home Affairs, Government of India.

4. Khan, F. (2011). Dementia in India: It’s high time to address the need! Arch Ment Health, 12, 64.

5. Patel, V., & Prince, M. (2001). Ageing and mental health in a developing country: Who cares? Qualitative studies from Goa, India. Psychol Med, 31, 29-38.

6. Murray, C. J., Lopez, A. D., & World Health Organization. (1996). The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020: Summary. Harvard: Harvard University Press.

7. Ferri, C. P., Prince, M., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., et al. (2005). Global prevalence of dementia: A Delphi consensus study. Lancet, 366, 2112-2117.

8. Ganguli, M., Chandra, V., Kamboh, M. I., Johnston, J. M., Dodge, H. H., Thelma, B. K., et al. (2000). Apolipoprotein E polymorphism and Alzheimer disease: The Indo US Cross National Dementia Study. Arch Neurol, 57, 824-830.

9. Yoshitake, T., Kiyohara, Y., Kato, I., Ohmura, T., Iwamoto, H., Nakayama, K., et al. (1995). Incidence and risk factors of vascular dementia and Alzheimer’s disease in a defined elderly Japanese population: The Hisayama study. Neurology, 45(6), 1161–1168.

10. Zhang, M., Katzman, R., Yu, E., Liu, W., Xiao, S. F., & Yan, H. (1998). A preliminary analysis of the incidence of dementia in Shanghai, China. Psychiatry Clin Neurosci, 52, S291–S294.

11. Nicolas, G., Acuña-Hidalgo, R., Keogh, M. J., Quenez, O., Steehouwer, M., Lelieveld, S., Rousseau, S., Richard, A. C., Oud, M. S., Marguet, F., Laquerrière, A., Morris, C. M., Attems, J., Smith, C., Ansorge, O., Al Sarraj, S., Frebourg, T., Campion, D., Hannequin, D., Wallon, D., Gilissen, C., Chinnery, P. F., Veltman, J. A., & Hoischen, A. (2018). Somatic variants in autosomal dominant genes are a rare cause of sporadic Alzheimer's disease. Alzheimers Dement, 14(12), 1632-1639.

12. Liljegren, M., Landqvist Waldö, M., Rydbeck, R., & Englund, E. (2018). Police Interactions Among Neuropathologically Confirmed Dementia Patients: Prevalence and Cause. Alzheimer Dis Assoc Disord, 32(4), 346-350.

13. Tong, B. C., Wu, A. J., Li, M., & Cheung, K. H. (2018). Calcium signaling in Alzheimer's disease and therapies. Biochim Biophys Acta Mol Cell Res, 1865(11 Pt B), 1745-1760.

14. Verma, M., Wills, Z., & Chu, C. T. (2018). Excitatory Dendritic Mitochondrial Calcium Toxicity: Implications for Parkinson's and Other Neurodegenerative Diseases. Front Neurosci, 12, 523.

15. Wallace, L., Theou, O., Rockwood, K., & Andrew, M. K. (2018). Relationship between frailty and Alzheimer's disease biomarkers: A scoping review. Alzheimers Dement (Amst), 10, 394-401.

16. Vik-Mo, A. O., Bencze, J., Ballard, C., Hortobágyi, T., & Aarsland, D. (2019). Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer's disease. J Neurol Neurosurg Psychiatry, 90(6), 728-730.

17. Reitz, C., & Mayeux, R. (2014). Alzheimer disease: epidemiology, diagnostic criteria, risk factors, and biomarkers. Biochem Pharmacol, 88(4), 640-645.

18. Schachter, A. S., & Davis, K. L. (2000). Alzheimer's disease. Dialogues Clin Neurosci, 2(2), 91-100.

19. O'Brien, J. T., & Thomas, A. (2015). Vascular dementia. Lancet, 386(10004), 1698-1706.

20. Kane, J. P. M., Surendranathan, A., Bentley, A., Barker, S. A. H., Taylor, J. P., Thomas, A. J., Allan, L. M., McNally, R. J., James, P. W., McKeith, I. G., Burn, D. J., & O'Brien, J. T. (2018). Clinical prevalence of Lewy body dementia. Alzheimers Res Ther, 10(1), 19.

21. Young, J. J., Lavakumar, M., Tampi, D., Balachandran, S., & Tampi, R. R. (2018). Frontotemporal dementia: latest evidence and clinical implications. Ther Adv Psychopharmacol, 8(1), 33-48

22. Uttley, L., Carroll, C., Wong, R., Hilton, D. A., & Stevenson, M. (2020). Creutzfeldt-Jakob disease: a systematic review of global incidence, prevalence, infectivity, and incubation. Lancet Infect Dis, 20(1), e2-e10.

23. Custodio, N., Montesinos, R., Lira, D., Herrera-Pérez, E., Bardales, Y., & Valeriano-Lorenzo, L. (2017). Mixed dementia: A review of the evidence. Dement Neuropsychol, 11(4), 364-370.

24. McKeith, I. (2004). Dementia with Lewy bodies. Dialogues Clin Neurosci, 6(3), 333-341.

25. McColgan, P., & Tabrizi, S. J. (2018). Huntington's disease: a clinical review. Eur J Neurol, 25(1), 24-34. 26. Salardini, A. (2019). An Overview of Primary Dementias as Clinicopathological Entities. Semin Neurol, 39(2), 153-166.

27. Clifford, D. B., & Ances, B. M. (2013). HIV-associated neurocognitive disorder. Lancet Infect Dis, 13(11), 976-986.

28. Gutwinski, S., Schreiter, S., Priller, J., Henssler, J., Wiers, C. E., & Heinz, A. (2018). Drink and Think: Impact of Alcohol on Cognitive Functions and Dementia - Evidence of Dose-Related Effects. Pharmacopsychiatry, 51(4), 136-143.

29. Uwagbai, O., & Kalish, V. B. (2022). Vascular Dementia. StatPearls [Internet]. StatPearls Publishing; Treasure Island, FL.

30. Kalaria, R. N. (2016). Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease. Acta Neuropathol, 131(5), 659-685.

31. Gomperts, S. N. (2016). Lewy Body Dementias: Dementia With Lewy Bodies and Parkinson Disease Dementia. Continuum (Minneap Minn), 22(2 Dementia), 435-463.

32. Masliah, E., Mallory, M., Deerinck, T., DeTeresa, R., Lamont, S., Miller, A., Terry, RD., Carragher, B., Ellisman, M. (1993). Re-evaluation of the structural organization of neuritic plaques in Alzheimer's disease. J Neuropathol Exp Neurol, 52(6), 619-632.

33. Amador-Ortiz, C., & Dickson, D.W. (2008). Neuropathology of hippocampal sclerosis. Handb Clin Neurol, 89, 569-572.

34. Mackenzie, I.R., & Neumann, M. (2016). Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. J Neurochem, 138(Suppl 1), 54-70.

35. Gambetti, P., Kong, Q., Zou, W., Parchi, P., & Chen, SG. (2003). Sporadic and familial CJD: classification and characterisation. Br Med Bull, 66, 213-239.

36. Finger, E.C. (2016). Frontotemporal Dementias. Continuum (Minneap Minn), 22(2 Dementia), 464-489.

37. Manix, M., Kalakoti, P., Henry, M., Thakur, J., Menger, R., Guthikonda, B., Nanda, A. (2015). Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurg Focus, 39(5), E2.

38. Strub, R.L. (2003). Vascular dementia. Ochsner J, 5(1), 40-43.

39. Deutschländer, A.B., Ross, O.A., Dickson, D.W., & Wszolek, Z.K. (2018). Atypical parkinsonian syndromes: a general neurologist's perspective. Eur J Neurol, 25(1), 41-58.

40. Alzheimer, A. (1911). Über eigenartige Krankheitsfälle des späteren Alters. Z Ges Neurol Psychiatr, 4(1), 356-385